- €932.98m
- €1.80bn
- €138.86m
- 47
- 74
- 86
- 81
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 106 | 120 | 113 | 128 | 139 |
Cost of Revenue | |||||
Gross Profit | 86.6 | 97.9 | 94.1 | 103 | 109 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18 | 33.4 | 31.6 | 8.71 | -13.7 |
Operating Profit | 87.8 | 86.7 | 81.6 | 119 | 153 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 55.9 | 61.1 | 63.8 | 135 | 175 |
Provision for Income Taxes | |||||
Net Income After Taxes | 54.5 | 58.1 | 61.4 | 132 | 181 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 54.5 | 58.1 | 61.4 | 132 | 181 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 54.5 | 58.1 | 61.4 | 132 | 181 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.86 | 4.72 | 4.91 | 10.3 | 13 |
Dividends per Share |